Allspring Global Investments
MYGN icon

Allspring Global Investments’s Myriad Genetics MYGN Stock Holding History

Allspring Global Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,172
Closed -$114K – 2168
2024
Q3 		$114K Sell
4,172
-2,549
-38% -$69K ﹤0.01% 1766
2024
Q2 		$164K Sell
6,721
-2,084
-24% -$45.7K ﹤0.01% 1753
2024
Q1 		$188K Buy
8,805
+4,193
+91% +$90.1K ﹤0.01% 1718
2023
Q4 		$88.3K Sell
4,612
-2,056
-31% -$35.6K ﹤0.01% 1816
2023
Q3 		$107K Buy
6,668
+336
+5% +$6.39K ﹤0.01% 1974
2023
Q2 		$147K Sell
6,332
-47,126
-88% -$1.03M ﹤0.01% 1910
2023
Q1 		$1.24M Buy
53,458
+46,108
+627% +$936K ﹤0.01% 1369
2022
Q4 		$107K Sell
7,350
-2,403
-25% -$44.8K ﹤0.01% 2053
2022
Q3 		$186K Buy
9,753
+3,861
+66% +$88.6K ﹤0.01% 1843
2022
Q2 		$107K Sell
5,892
-97,786
-94% -$2.03M ﹤0.01% 2039
2022
Q1 		$2.61M Buy
103,678
+64,665
+166% +$1.65M ﹤0.01% 1370
2021
Q4 		$1.08M Buy
+39,013
New +$1.13M ﹤0.01% 1894

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Allspring Global Investments's MYGN Position: Q4 2024 in Review

Allspring Global Investments sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 4,172 shares — an estimated $114K sold.

Allspring Global Investments first reported a position in MYGN in Q4 2021 and held it in 12 quarters. The position peaked at $2.61M in Q1 2022. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • Allspring Global Investments reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 4,172 Myriad Genetics shares in Q4 2024, an estimated $114K.
  • Allspring Global Investments first reported a position in Myriad Genetics in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Myriad Genetics position peaked at $2.61M in Q1 2022.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.